Malaria Transmission After Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine: A Randomized...
Malaria Transmission After Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine: A Randomized Trial
About this item
Full title
Author / Creator
Sawa, Patrick , Shekalaghe, Seif A. , Drakeley, Chris J. , Sutherland, Colin J. , Mweresa, Collins K. , Baidjoe, Amrish Y. , Manjurano, Alphaxard , Kavishe, Reginald A. , Beshir, Khalid B. , Yussuf, Rahma U. , Omar, Sabah A. , Hermsen, Cornelus C. , Okell, Lucy , Schallig, Henk D. F. H. , Sauerwein, Robert W. , Hallett, Rachel L. and Bousema, Teun
Publisher
Oxford: Oxford University Press
Journal title
Language
English
Formats
Publication information
Publisher
Oxford: Oxford University Press
Subjects
More information
Scope and Contents
Contents
Background. Artemisinin-based combination therapy (ACT) reduces the potential for malaria transmission, compared with non-ACTs. It is unclear whether this effect differs between ACTs. Methods. A total of 298 children (age, 6 months to 10 years) with uncomplicated falciparum malaria were randomized to artemether-lumefantrine (AL; n = 153) or dihydro...
Alternative Titles
Full title
Malaria Transmission After Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine: A Randomized Trial
Authors, Artists and Contributors
Author / Creator
Shekalaghe, Seif A.
Drakeley, Chris J.
Sutherland, Colin J.
Mweresa, Collins K.
Baidjoe, Amrish Y.
Manjurano, Alphaxard
Kavishe, Reginald A.
Beshir, Khalid B.
Yussuf, Rahma U.
Omar, Sabah A.
Hermsen, Cornelus C.
Okell, Lucy
Schallig, Henk D. F. H.
Sauerwein, Robert W.
Hallett, Rachel L.
Bousema, Teun
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1347258120
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1347258120
Other Identifiers
ISSN
0022-1899
E-ISSN
1537-6613
DOI
10.1093/infdis/jit077
